We connected presidential election campaigns, human-computer chess competitions, and happier medical patients in our presentation at the recent eyeforpharma Philadelphia 2013 conference.
The presentation considers certain fields in which the big data movement has been beneficially spreading, including the impact it’s had so far in pharmaceuticals. We posit that in the industry’s most vital customer interactions between sales reps and healthcare providers, big data benefits tend to not yet be fully realized. As sales reps increasingly get the right data when, where and how they need it, they can improve their decision making in the field. This can strengthen activities throughout sales cycles. Leveraging big data capabilities for better integration of rep actions with multi-channel activities can be especially beneficial.
Aktana CEO David Ehrlich presented our perspective on these issues at eyeforpharma Philadelphia 2013, which we’re pleased to be able to share.